Cosmetic Pen and Pencil Market - Regional Analysis
Asia Pacific Market Insights
Asia Pacific industry is predicted to account for largest revenue share of 30% by 2035. In 2021, about 31% of people purchased cosmetics online in India. The surge in users of cosmetic products is expected to drive the cosmetic pen and pencil market in Asia Pacific. According to the International Trade Commission, in 2020, China has the largest market for cosmetic products and out of all the products, makeup products constituted 12% share.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of cosmetic pen and pencil is assessed at USD 3.91 billion.
The global cosmetic pen and pencil market size was valued at more than USD 3.65 billion in 2025 and is expected to register a CAGR of over 7.8%, exceeding USD 7.74 billion revenue by 2035.
The cosmetic pen and pencil market in Asia Pacific is anticipated to command a 30% revenue share by 2035, attributed to the surge in users of cosmetic products.
Key players in the market include CELLECTAR BIOSCIENCES, INC., APEIRON Biologics AG, Pfizer Inc., Eli Lilly and Company, AstraZeneca, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, MacroGenics Inc., Marsala Biotech Inc., Johnson & Johnson Services, Inc.
